Duloxetine: A new psychopharmacologic treatment option for fibromyalgia?

Current Psychiatry Reports

Volumn 10, Issue 3, 2008, Pages 237-239

  Pae, Chi Un ^a,b,c,d   Masand, Prakash ^{a,b,d,e,f,g,h,i}  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Lundbeck ^*

^c ASTRAZENECA   (United Kingdom)

^d ELI LILLY AND COMPANY   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f Forest Laboratories

^g JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^h JAZZ PHARMACEUTICALS   (United States)

ⁱ PFIZER

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; MILNACIPRAN; PLACEBO; PREGABALIN;

ANALGESIC ACTIVITY; BECK DEPRESSION INVENTORY; BRIEF PAIN INVENTORY; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; FIBROMYALGIA; FUNCTIONAL DISEASE; HUMAN; PSYCHOPHARMACOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SHORT FORM 36; SHORT SURVEY; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 49249112767     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-008-0039-9     Document Type: Short Survey

References (9)

1. Offenbaecher M, Glatzeder K, Ackenheil M: Self-reported depression, familial history of depression and fibromyalgia (FM), and psychological distress in patients with FM. Z Rheumatol 1998, 57(Suppl 2):94-96.
2. Arnold LM, Keck PE Jr, Welge JA: Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000, 41:104-113.
3. Frank L, Revicki DA, Sorensen SV, Shih YC: The economics of selective serotonin reuptake inhibitors in depression: a critical review. CNS Drugs 2001, 15:59-83.
4. Jann MW, Slade JH: Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy 2007, 27:1571-1587.
5. US Food and Drug Administration: Duloxetine prescribing information. http://www.fda.gov/cder/foi/label/2004/21733lbl.pdf. Accessed April 2, 2008.
6. Arnold LM, Lu Y, Crofford LJ, et al.: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004, 50:2974-2984.
7. Arnold LM, Rosen A, Pritchett YL, et al.: A randomized, double-blind placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005, 119:5-15.
8. US Food and Drug Administration: FDA approves first drug for treating fibromyalgia. http://www.fda.gov/bbs/topics/NEWS/2007/NEW01656.html. Accessed April 2, 2008.
9. Patkar A, Masand PS, Krulewicz S, et al.: A randomized, double-blind, placebo-controlled study of controlled release paroxetine in the treatment of fibromyalgia syndrome. Am J Med 2007, 120:448-454.